Peetz Christopher
- SEC CIK
- 0001614740
In the past year, 8 open-market sale filings worth $16.3M and no purchases.
Current role at each company
- MIRM Mirum Pharmaceuticals, Inc.CHIEF EXECUTIVE OFFICERas of Sep 3, 2026
- ARQT Arcutis Biotherapeutics, Inc.Directoras of Jul 17, 2026
- ALPN Alpine Immune Sciences, Inc.Directoras of May 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $16.3M
- 8 filings
- Net
- −$16.3M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Peetz Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MIRM Mirum Pharmaceuticals, Inc.
CHIEF EXECUTIVE OFFICER21 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 (view filing) | Oct 1 | Same day | Peetz ChristopherPresident and CEO | SSale | −3.67K | $19.26 | −$70.7K | −14.9%21.0K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Peetz ChristopherPresident and CEO | PPurchase | +7.00K | $14.40 | +$100.8K | +33.3%28.0K after | |
| Jul 5, 2023 (view filing) | Jul 3 | 2 days | Peetz ChristopherPresident and CEO | SSale | −5.50K | $25.65 | −$141.0K | −4.6%115.3K after | |
| Jan 9, 2024 (view filing) | Jan 8 | 1 day | Peetz ChristopherPRESIDENT AND CEO | SSale | −5.21K | $28.03 | −$146.0K | −4.5%110.1K after | |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −6.01K | $26.19 | −$157.5K | −5.5%104.1K after | |
| Mar 18, 2024 (view filing) | Jan 9, 2023 | 434 daysLate | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −5.16K | $20.62 | −$106.4K | −5.3%92.0K after | |
| Jan 8, 2025 (view filing) | Jan 7 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −7.49K | $42.82 | −$320.7K | −5.9%119.4K after | |
| Jan 27, 2025 (view filing) | Jan 24 | 3 days | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −6.84K | $47.92 | −$327.6K | −5.2%125.0K after | |
| Feb 4, 2025 (view filing) | Feb 3 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −9.10K | $48.22 | −$438.9K | −7.3%115.9K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Peetz ChristopherCHIEF EXECUTIVE OFFICER | SSale | −40.0K | $46.91 | −$1.88M | −25.7%115.9K after | 2 lots10b5-1 |
ALPN Alpine Immune Sciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2021 (view filing) | Sep 23 | 4 days | Peetz ChristopherDirector | PPurchase | +1.90K | $10.17 | +$19.3K | New position1.90K after | Amended |